ORMP - Oramed Pharmaceuticals Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 572.79M
Enterprise Value 342.33M
Trailing P/E N/A
Forward P/E 1-5.23
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)26.93
Price/Book (mrq)4.14
Enterprise Value/Revenue 315.66
Enterprise Value/EBITDA 6-3.41

Trading Information

Stock Price History

Beta (5Y Monthly) 1.64
52-Week Change 323.05%
S&P500 52-Week Change 36.24%
52 Week High 36.0500
52 Week Low 32.3200
50-Day Moving Average 35.0229
200-Day Moving Average 33.9700

Share Statistics

Avg Vol (3 month) 3241.81k
Avg Vol (10 day) 3260.43k
Shares Outstanding 517.84M
Float 14.87M
% Held by Insiders 117.49%
% Held by Institutions 119.97%
Shares Short (Feb 13, 2020) 4549.68k
Short Ratio (Feb 13, 2020) 46.2
Short % of Float (Feb 13, 2020) 43.81%
Short % of Shares Outstanding (Feb 13, 2020) 43.09%
Shares Short (prior month Jan 14, 2020) 4442.31k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Jan 22, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug 30, 2019
Most Recent Quarter (mrq)Nov 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)-459.49%

Management Effectiveness

Return on Assets (ttm)-20.77%
Return on Equity (ttm)-54.74%

Income Statement

Revenue (ttm)2.7M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)2.61M
EBITDA -12.41M
Net Income Avi to Common (ttm)-12.6M
Diluted EPS (ttm)-0.7210
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.13M
Total Cash Per Share (mrq)1.7
Total Debt (mrq)106k
Total Debt/Equity (mrq)0.62
Current Ratio (mrq)6.62
Book Value Per Share (mrq)0.99

Cash Flow Statement

Operating Cash Flow (ttm)-11.8M
Levered Free Cash Flow (ttm)-6.36M